Long acting injectable insulin composition and methods of making and using thereof
US7544656B2 · kind B2 · utility
29Cited by
7References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 4, 2004 |
| Grant date | Jun 9, 2009 |
| Priority date | — |
| Expiry date | Nov 7, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of lowering blood glucose in a mammal includes injecting a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin over an extended period of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.